HeartCore Enterprises Reports Q2 2026 Financial Results with Increased Revenue but Higher Losses

HeartCore Enterprises, Inc. reported its financial results for the second quarter of 2026, revealing a significant decline in profitability compared to the same period in 2025. The company generated revenues of $321,428 for the three months ended June 30, 2026, a 71.6% increase from $187,277 in the prior year. However, the cost of revenues surged by 86.3% to $391,643, leading to a gross loss of $70,215, compared to a gross loss of $22,965 in the previous year. For the six months ended June 30, 2026, revenues totaled $553,926, up 25.9% from $439,909, but the company reported a net loss of $4,016,234, a substantial increase from a loss of $2,075,875 in the same period of 2025.

The financial performance reflects a strategic shift following the sale of its software business in Japan and a focus on Go IPO consulting services. The company has entered into consulting agreements with 16 companies to assist them in their IPO processes, which has contributed to increased revenue from software development services. However, revenue from Go IPO consulting services decreased due to extended timelines for clients' IPOs. The company also experienced a significant increase in operating expenses, which rose to $1,958,091 for the six months ended June 30, 2026, compared to $1,923,502 in the prior year.

Operationally, HeartCore's customer base has become more concentrated, with a few key clients accounting for a substantial portion of revenues. As of June 30, 2026, the company had cash and cash equivalents of $587,074, down from $1,904,826 at the end of 2025. The company’s working capital stood at $604,040, indicating a tight liquidity position. The filing also noted that the company incurred net cash flows used in operating activities of $2,482,756 for the six months ended June 30, 2026, compared to $1,965,478 in the previous year.

In terms of strategic developments, HeartCore completed the sale of its 51% interest in Sigmaways and its subsidiaries on June 22, 2026, for a total consideration of up to $650,000, which includes an earn-out based on future performance. Additionally, the company is in the process of selling its 51% interest in HeartCore Luvina, with the transaction expected to close shortly. The company has also implemented a share repurchase program, authorizing up to $2 million for repurchases of its common stock, although no shares have been repurchased to date.

Looking ahead, HeartCore's management is focused on exploring strategic alternatives to enhance liquidity and operational efficiency. The company plans to continue its Go IPO consulting services while managing costs and seeking additional funding sources. However, the ongoing macroeconomic challenges and the concentration of revenue among a limited number of clients present risks to its financial stability and growth prospects.